Accumulating evidence has revealed that mitochondria dynamics and function regulation is essential for the successful mesenchymal stem cell (MSC) differentiation. In the present study, the researchers reported for the first time that Mtu1 defects are correlated with reduced osteogenic differentiation. Using in vitro cultured bone marrow MSCs and stromal cell line MS5, we demonstrated that depressed Mtu1 expression was associated with reduced 2-thiouridine modification of the U34 of mitochondrial tRNAGln, tRNAGlu, and tRNALys, which led to respiratory deficiencies and reduced mitochondrial ATP production, and finally suppressed osteogenic differentiation. As expected, these Mtu1-deficient mice exhibited obvious osteopenia. Therefore, our findings in this study provide new insights into the pathophysiology of osteopenia.
Mesenchymal stem cells (MSCs), which are multipotent cells readily accessible from various tissues and give rise to mesoderm cell lineages such as osteoblasts and adipocytes, have been widely studied over the past two decades. Cell-based regenerative therapies using MSCs are emerging as promising therapeutic approaches in various diseases, such as bone and cartilage, cardiovascular, autoimmune, and liver diseases, and cancer1,2,3,4,5. However, the specific mechanisms regulating the fate of MSCs are still not fully understood.
In mammalian cells, mitochondria are the major energy source, which provide ATP through oxidative phosphorylation (OXPHOS), and also play a critical role in reactive oxygen species (ROS) production and programmed cell death (apoptosis)6,7,8. Recent studies have demonstrated the importance of mitochondrial metabolism in regulating stem cell biology. Like other stem cells, MSCs own a relatively low mitochondria activity until the start of cell differentiation9,10. Marked changes in mitochondrial DNA (mtDNA) copy number, protein levels of respiratory enzymes, oxygen consumption rates (OCRs), mRNA levels of mitochondrial biogenesis-associated genes, and intracellular ATP content were observed upon differentiation induction11,12,13,14. These studies indicate that mitochondria play an important regulatory role in differentiation capacity of MSCs15. Understanding the roles of mitochondrial dynamics during MSC differentiation will facilitate the optimization of differentiation protocols, and ultimately, benefit the development of new pharmacologic strategies in regenerative medicine.
Mitochondrial defects have been associated with a wide spectrum of degenerative diseases, aging, and cancer16,17,18. Previous studies demonstrate that global knockout mouse models of mitochondrial genes are heterozygous haploinsufficient and homozygous-lethal19. Furthermore, the abolished of OXPHOS resulted in embryonic lethality approximately at the time of organogenesis, suggesting the importance of mitochondria in cell differentiation20,21,22,23. More appropriate models are needed to better delineate the role of mitochondrial dysfunction during stem cell differentiation. In the present study, heterozygous Mtu1 (also known as Trmu, a mitochondrial-tRNA-modifying enzyme) knockout mice that exhibited symptoms of osteopenia were adopted as a potential model. This Mtu1 deficiency was further evaluated for its effects on mitochondrial translation, respiration, and ATP production using primary bone marrow MSCs and MS5 stromal cell line.
Materials and Methods
C57BL/6 mice were purchased from Shanghai SLAC Animal Inc. (Shanghai, China). The Mtu1 knockout mice were generated using the CRISPR/Cas9 method. Briefly, C57BL/6 female mice were superovulated and mated with C57BL/6 males, and fertilized eggs were collected from the oviduct. The pronuclear stage eggs were injected with Cas9 mRNA and sgRNA. The eggs were cultivated in KSOM overnight then transferred into the oviducts of pseudopregnant ICR females. The sequence of sgRNA used for Mtu1 is 5′-CACGTCGTGTGCTCCCTGTC-3′. Genomic DNA was extracted from the tails, and a DNA fragment surrounding the target site was PCR-amplified with specific primers to identify the genotype of the offspring. The PCR primers are as follows: forward 5′-ACTTCCGGCGTAGCTTGGA-3′ and reverse 5′-ATGCGGAGAGGTTGACACAA-3′. Mice were housed on a 12-h light/dark cycle, and provided food and water ad libitum in the Experimental Animal Center of Zhejiang University. The research was approved by the Animal Ethic Committee of Zhejiang University (Ethical Approval Code: 17264). Experiments and animal care were performed in accordance with the guidelines of Zhejiang University.
MS5 stromal cell line
MS5 stromal cell line, a type of mouse adherent fibroblastic cells growing in monolayers, was obtained from Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures GmbH. The cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM, Hyclone) supplemented with 10% fetal bovine serum (FBS, Gemini) at 37 °C with 5% CO2.
Knockdown of Mtu1 in MS5 stromal cells
The shRNAs containing a hairpin loop were synthesized and inserted into the pLKO.1-puro vector, and the sequences were shown in Supplementary Table S1. Lentiviral vectors, and pLKO.1 with shRNA were co-transfected into HEK293T cells with psPAX2 and pMD2.G for lentivirus production24. 2 days after infection, the transduced cells were selected using 1 µg/mL puromycin over a two-week period, resulting in homogeneous populations.
Cell isolation and culture of mouse BM-MSCs
BM-MSCs were prepared as previously described25. Femurs and tibias from wild type and Mtu1+/− mice (four-month-old) were dissected and flushed with PBS. The bones were chopped and incubated for 1.5 h at 37 °C in 10 mL of DMEM containing 1 mg/mL collagenase II. The pellet was collected by centrifugation at 800 g for 4 min and cultured in Minimum Essential Medium Eagle - Alpha Modification (Alpha MEM, Hyclone) supplemented with 10% FBS and 1% penicillin/streptomycin at 37 °C with 5% CO2. After 3 days, nonadherent cells and debris were removed and the adherent cells were continuously cultured.
Cells were trypsinized, washed in PBS, and stained with the following anti-mouse antibodies: CD44-phycoerythrin (PE; cat:130-102-606), CD45-PE (cat:130-102-781), F4/80-fluorescein isothiocyanate (cat:130-102-327), and Sca-1-allophycocyanin (cat:130-102-343) from Miltenyi Biotec. The samples were processed using a NovoCyte flow cytometer (ACEA Biosciences) and analyzed using the NovoExpress software.
Western blot analysis
Here, 20 µg of total cellular proteins obtained from MSCs were denatured and loaded on sodium dodecyl sulfate polyacrylamide gels. After electrophoresis, the gels were transferred to a PVDF membrane (Millipore) and processed for immunoblotting. Commercially available antibodies, such as MTU1 (ab50895), ND5 (ab92624), NDUFB8 (ab110242), SDHB (ab14714), UQCRC2 (ab14745), ATP5a (ab14748), and MTCO1 (ab17405) from Abcam, ATP6 (55313-1-AP), GAPDH (60004-1-Ig), and VDAC (55259-1-AP) from Proteintech, NDUFS1 (A16926), NDUFS2 (A12858), ND4 (A17970), and CYTB (A17966) from Abclonal were used. Peroxidase AffiniPure Goat Anti-Mouse IgG and Goat Anti-Rabbit IgG (Jackson) were used as secondary antibodies, and the protein signals were detected using the ECL system. Band intensities were quantified from the 16-bit digital image by densitometry in ImageJ and are shown normalized to GAPDH for each target.
Quantitative real-time PCR
The extracted total RNAs were reverse-transcribed into complementary DNA using the PrimeScript™ RT Reagent Kit (Takara), and quantitative real-time PCR analyses were performed using an Applied Biosystems Prism 7900 System with gene-specific primers. Data were normalized to the mRNA levels of Gapdh that was used as a housekeeping gene and were analyzed using the 2−ΔΔCT method. Detailed primer sequences are provided in Supplementary Table S1.
Bone structure analysis
To evaluated the bone mineral density (BMD) and microarchitecture of femur trabeculae in mice, male mice at 6 weeks, 12 weeks, and 48 weeks ages were scanned in a U-CT system (MILabs U-CT, Netherlands). Datasets were reconstructed using MILabs Rec 10.16 software. Trabecular BMD, BS/BV, BV/TV, Tb.Th, and Tb.Sp were calculated from the region of interest (ROI). The μCT data were evaluated and three-dimensional bone structure image slices were reconstructed using the IMALYTICS Preclinical 2.1 software.
Transcriptome-seq and bioinformatic analysis
The total RNAs were isolated using TRIzol reagent (Ambion Inc.) following the manufacturer’s procedure. The total RNA quantity and purity were analysis of Bioanalyzer 2100 and RNA 6000 Nano Lab Chip Kit (Agilent, CA, USA) with RIN number >7.0. cDNA libraries were generated using NEB Next Ultra Directional RNA Library Prep Kit (NEB), and then sequenced using the Illumina sequencing technology on an Illumina Hiseq 4000 at LC Bio (Zhejiang, China) according to the recommended protocols. Paired-end clean reads were mapped to the mouse reference genome GRCm38/mm10 using TopHat software26. The genome-matching reads were used to measure mRNA abundance using Cufflinks software27. The mRNAs at a cut-off of 10 reads were compared and considered as differentially expressed if the fold change > 2 and P value < 0.05. Gene set enrichment analysis (GSEA) was performed by inputting a list in which differentially expressed genes were ranked according to their fold change, into GSEA application28. KEGG pathway analysis was performed using Cluster Profiler R package. The RNA sequencing (RNA-Seq) data were deposited into Sequence Read Archive (SRA) with the Bioproject ID of PRJNA670203.
Statistical analysis was carried out based on at least three independent experiments using unpaired two-tailed Student’s t-test (or ANOVA) in the GraphPad Prism seven program. The error bars indicate two standard deviations of the means. Differences were considered significant at a P value of <0.05.
Other detailed methods are available in the Supplementary Material and Methods online.
Osteopenia induced in Mtu1-deficient mice
Researchers generated a 35-bp insertion, which caused a frameshift from codon 10 and then terminated early at codon 11, in the exon 1 of Mtu1 knockout mice through CRISPR/Cas9 technology to test the role of Mtu1 in MSC differentiation (Fig. 1A). This allele was subsequently propagated after confirming the mutation by Sanger sequencing, agarose gel electrophoresis and Western blot analysis (Fig. 1B–D). There was no Mtu1−/− mice obtained after multiple generations of breeding, which was consistent with previous research that Mtu1−/− mice result in embryonic lethality around E7.5-829.
Like the wild-type mice, Mtu1+/− mice exhibited normal body size and lifespan. The researchers tested their femur health at different ages in a U-CT system (Fig. 1E). The results showed decreased bone volume per tissue volume (BV/TV; Fig. 1F), trabecular thickness (Tb.Th; Fig. 1G), as well as significant increased specific bond surface (BS/BV; Fig. 1H) and trabecular separation (Tb.Sp; Fig. 1I), indicating significant poor bone quality in Mtu1+/− mice compared with wild type mice. In addition, the quality of Trabecular (bone mineral density; BMD; Fig. 1J) was also significantly lower in Mtu1+/− mice. Given these observations from the μCT analysis, we proposed that Mtu1 deficiency could contribute to bone loss and dysplasia, resulting in the pathophysiology of osteopenia. Furthermore, hematoxylin/eosin (H&E) staining of femur sections also showed a shortening of the trabecular bone in four-week-old Mtu1+/− mice, compared with the Mtu1+/+ littermates (Fig. 1K). In the meanwhile, ALP, a sensitive and reliable indicator of bone metabolism reflecting biosynthetic activity of the bone-forming cells, was also found decreased in Mtu1+/− mice femur sections (Fig. 1L, M). These findings indicated that Mtu1 mutant resulted in abnormal bone development in mice.
Generation of BM-MSCs from Mtu1 knockout mice
BM-MSCs were isolated from four-month-old mice to further investigate the influence of Mtu1 deficiency on MSC differentiation. These MSCs were purified by adherence to plastic and identified using expression of cell-surface markers, such as CD44 and Sca-1, and lack of expression of F4/80 and CD45 surface molecules30,31. As shown in Fig. 2A, the Mtu1+/− MSCs displayed the same morphology as the Mtu1+/+ control, and flow cytometric analysis indicated that both genotypes contained a consistent subset surface marker (CD44+Sca-1+CD45−F4/80−) (Fig. 2B).
The BM-MSCs isolated from Mtu1+/− mice showed a significantly reduced level of Mtu1 (60% relative to the wild-type, Fig. 1D). The researchers then evaluated the 2-thiouridylation levels of tRNAGln, tRNAGlu, and tRNALys through electrophoresis mobility retardation in polyacrylamide gel containing 0.05 mg/ml ((N-acryloylamino)phenyl) mercuric chloride (APM)32,33, with tRNALeu(UUR) as the negative control. In this system, the upper band represented the thiouridylated tRNA, and the lower band was unthiouridylated tRNA. As shown in Fig. 2C, D, the 2-thiouridylation levels of tRNAGln, tRNAGlu, and tRNALys were reduced in Mtu1+/− BM-MSCs, compared with wild type BM-MSCs. The 2-thiouridylation proportions of tRNAGln, tRNAGlu, and tRNALys in Mtu1+/− BM-MSCs were 49.9%, 53.1%, and 84.8%, respectively, whereas those in wild-type BM-MSCs were 58.0%, 61.0%, and 88.0%, respectively. In addition, the downregulation of cellular proliferation and G2 phase cell cycle arrest suggested that Mtu1+/− BM-MSCs growth was repressed (Fig. 2E, F). These results indicated that Mtu1+/− mice did affect the 2-thiouridylation levels of mitochondrial tRNAs and slow the cell growth but not the basal characteristics of MSCs, such as morphology and cell-surface markers.
Reduced osteogenic differentiation capacity in Mtu1 +/− BM-MSCs
Osteogenic and adipogenic differentiation were induced to verify whether Mtu1 defects affected MSCs in terms of giving rise to lineage cells. The Alizarin Red S staining manifested that the intensity of mineralized calcium was decreased in Mtu1+/− after 14 days of osteogenic differentiation (Fig. 3A), and the quantitative analysis of calcium nodule levels evidenced a statistically significantly reduced by 73.1% (Fig. 3B). In addition, qPCR analysis also revealed decreased osteoblast markers (Runx2, Ocn, and Alp) in mutant cells during osteogenic differentiation (Fig. 3C).
Moreover, at the end of adipogenic differentiation, on day 14, Oil Red O staining was performed to visualize the accumulated lipid droplets in differentiated adipocytes. The result showed that there was no significant change of lipid accumulation in Mtu1+/−, compared with the wild-type (Fig. 3D, E), which was confirmed by assessing adipogenic marker gene expression (Lpl and PPARγ) (Fig. 3F).
Mitochondrial dysfunctions in Mtu1 +/− BM-MSCs
Previous studies have shown that the 2-thiouridylated modification reduction caused by Mtu1 defects can affect mitochondrial protein translation29,34,35. 13 subunits encoded by mtDNA and >70 subunits encoded by the nuclear genome together form the OXPHOS complexes (CI~CV). The researchers typically examined the levels of five mtDNA-encoding polypeptides (Nd4, Nd5, Cytb, Co1 and Atp6) and six nDNA-encoding polypeptides (Ndufs1, Ndufs2, Ndufb8, Sdhb, Uqcrc2, and Atp5a) through Western blotting with Vdac as a loading control, to investigate whether the Mtu1 knockout impaired mitochondrial OXPHOS complexes in MSCs. Notably, the protein levels of Nd4, Ndufs1, Ndufs2, and Ndufb8 (CI) as well as Cytb (CIII), Co1 (CIV) showed an evident reduction in Mtu1+/− BM-MSCs compared with the control group (Fig. 4A). It was also found that Nd5 and Atp6 remained at lower levels in Mtu1+/− BM-MSCs.
Generally, in adipogenesis and osteogenesis differentiated cells, increased mitochondrial biogenesis was observed, increasing abundance of mitochondria15. Here, the researchers determined the OCR of undifferentiated and osteogenesis cells. For BM-MSCs from wild type mice, the energetics analysis showed that the basal, ATP-linked, and maximal respiration, as well as reserve capacity were increased after osteogenesis differentiation (Fig. 4B). Both undifferentiated and osteogenesis Mtu1+/− BM-MSCs had reduced basal, ATP-linked, maximal respiration, and reserve capacity (Fig. 4C). Moreover, the results of the ATP production levels in undifferentiated and osteogenesis cells were consistent with those of the OCR assay (Fig. 4D). Furthermore, the mitochondrial ROS production was decreased after osteogenesis differentiation, and Mtu1+/− BM-MSCs showed increased mitochondrial ROS production in osteogenesis cells, compared with the control group (Fig. 4E). These results demonstrated that Mtu1 deficiency leads to impaired mitochondrial translation and respiratory activities both in undifferentiated and osteogenesis BM-MSCs, and the impairments were magnified in osteogenic differentiation.
Knockdown of Mtu1 in MS5
To further explore the effects of Mtu1 on osteogenesis differentiation, the MS5 stromal cell line was utilized for the shRNA-mediated Mtu1-knockdown experiment. The Mtu1 level in the resultant stable cell lines was examined by Western blotting, and the shMtu1_2 cell line demonstrated a significant decrease of Mtu1 expression level compared with control and shScramble cell lines (Fig. 5A). Flow cytometric analysis indicated that both shScramble and shMtu1_2 cells contained a consistent subset surface marker (CD44+Sca-1+CD45−F4/80−) similar to control cells (Fig. 5B). Apart from this, the cell morphology of Mtu1 knockdown did not significantly change (data not shown). The APM gel analysis showed a significant reduction in the 2-thiouridylation levels of tRNAGln, tRNAGlu, and tRNALys in the Mtu1 knockdown cell lines, as compared with those in control and shScramble groups (Fig. 5C). The proportions of the 2-thiouridylation levels of tRNAGln, tRNAGlu, and tRNALys in Mtu1 knockdown cell lines were 16.4%, 20.2%, and 10.8%, respectively, whereas those in the scrambled cell lines were 53.1%, 54.6%, and 35.6%, and they were 50.0%, 51.5%, and 36.5%, respectively, in the control cell lines (Fig. 5D).
Similarly, osteogenic and adipogenic differentiation were performed for control, shScramble, and shMtu1_2 cell lines, respectively. The shMtu1_2 cells manifested a 92.5% reduction of mineralized calcium intensity after 14 days of osteogenic differentiation compared with the control group (Fig. 5E, F) and also revealed decreased osteoblast markers Runx2, Ocn and Alp during osteogenic differentiation (Fig. 5G). Furthermore, lipid accumulation and adipogenic marker gene expression (Lpl and PPARγ) were indistinguishable among control, shScramble, and shMtu1_2 cells (Supplementary Fig. S1).
Accordingly, the mitochondrial respiratory chain associated polypeptides were impaired in shMtu1_2 cells, which was consistent with these findings in Mtu1+/− BM-MSCs (Supplementary Fig. S2A). A broad and significant decrease in the activities of Complexes I, III, and IV resulted from disruption of mitochondrial translation and the activities of Complexes I, II, III, and IV in shMtu1_2 cell lines were 43.6%, 92.6%, 72.9%, and 69.3%, respectively, of the mean value measured in the control cells (Fig. S3B). Compared with Mtu1+/− BM-MSCs, Mtu1 knockdown in MS5 cells showed more remarkable alterations in mitochondrial respiratory chain function, ATP synthesis and oxidative stress (Supplementary Figs. S2C–F).
Alterations in transcriptome analyzed by RNA-seq
Researchers performed RNA-seq analyses of both shScramble and shMtu1_2 cells to identify the molecular mechanism underlying the MSC osteogenesis differentiation in the Mtu1-deficient group. Compared with shScramble cells, the expression levels of 4197 genes were significantly altered following Mtu1 knockdown (Fig. 6A). Among these differentially expressed genes, 3394 genes were downregulated, and 803 genes were upregulated. By comparing the results to mouse MitoCarta3.0, an inventory of mammalian mitochondrial proteins36, 174 genes related to mitochondrial metabolism were found to be statistically different between control and mutant group (Fig. 6B and Supplementary Table S2), including 51 upregulated genes and 123 downregulated genes. The proteins encoded by these altered genes were involved in various mitochondrial metabolisms, including mitochondrial DNA transcription and translation, ribosomal, autophagy, amino acid metabolism and so on (Fig. 6C, D; Supplementary Fig. S3). Meanwhile, there was a downtrend of the mitochondrial DNA encoded transcripts in shMtu1_2 cells, indicating the dysfunction of mitochondrial transcription and translation system in shMtu1_2 cells (Fig. 6E). These results demonstrated that the defect of Mtu1 seriously impacted on mitochondrial biogenesis and metabolism of mesenchymal stem cells.
A biological pathway distribution was observed in KEGG (kyoto encyclopedia of genes and genomes) enrichment analysis (Fig. 6F). There were various signaling pathways influenced by Mtu1 deficiency, including FoxO (forkhead box), TNF (tumor necrosis factor), mTOR, and MAPK (mitogen-activated protein kinase). The signaling pathways were associated with apoptosis, glucose metabolism, oxidative stress resistance, cell proliferation, differentiation, inflammation, immunity and so on. Notably, the FoxO signaling pathway was reported playing key roles in osteoblast differentiation and bone formation37,38,39. Thus, the downregulated FoxO signaling pathway might be the decisive mechanism linking Mtu1 deficiency to dysfunction in osteogenesis.
In the present study, the researchers investigated the roles of Mtu1 in MSC differentiation progress. Mtu1 is a highly conserved mitochondrial enzyme that catalyzes the 2-thiolation of 5-taurinomethyl-2-thiouridine (τm5s2U) found in the anticodon of a subset of mitochondrial tRNAs (mt-tRNAs), including mitochondrial tRNAGln, tRNAGlu and tRNALys 40,41. Consequently, Mtu1 deficiency resulted in a loss of 2-thiouridylation in mt-tRNAs, leading to a marked mitochondrial translation impairment. Genetic mutations in MTU1 have been identified in reversible infantile liver failure patients and also in hearing loss pedigrees, as the researchers have previously reported. Interestingly, the researchers generated Mtu1 knockout mice and found that these embryonic homozygous-lethal genes failed to develop bone anabolism, and the heterozygous also exhibited symptoms of osteopenia.
Mitochondrial activity or dormancy expectedly plays an important role in maintaining the stemness of MSCs, whereas proper activation is essential for successful differentiation. In fact, τm5s2U modification is necessary for decoding UUG codons; thus, the deficient modifications at the wobble position of tRNAs led to increased mistranslation41. Supporting this speculation, Björk GR et al. showed that a complete loss of the mcm5s2 modification, the cytosolic counterpart of τm5s2, resulted in a lethal phenotype in yeast42. In this study, the constitutive knockout mice (Mtu1−∕−) were embryonic-lethal at a very early developmental stage (prior to day 8.5).
Compared with Mtu1−∕− mutants, the phenotypes of Mtu1+/− mice were rather moderate. Researchers isolated mouse BM-MSCs from the femurs and tibias of Mtu1+/− and Mtu1+/+ littermates. The inactivation of Mtu1 significantly reduced the 2-thiouridylation in mitochondrial tRNAGln, tRNAGlu and tRNALys in Mtu1+/− BM-MSCs and MS5 stromal cells treated with Mtu1 shRNA. The deficient modifications at wobble position of tRNAs affected the decoding accuracy through altered codon-anticodon interactions and then led to mistranslation43. Notably, the decreased steady-state levels of OXPHOS complexes subunits indicated the disruption of mitochondrial translation as well as respiratory chain in Mtu1 deficient cells and consequently resulted in a broad and significant decrease in the activities of Complexes I, III, IV. Furthermore, alterations in mitochondrial translation and respiratory activities led to reduced basal OCR, ATP-linked OCR, reserve capacity and maximal OCR in Mtu1 deficient cells, compared with the controls. The respiratory deficiency then affects the efficiency of mitochondrial ATP synthesis. Several studies have proven that metabolic activity conditions are different between MSCs and differentiated offspring cells10,12. The original MSCs are maintained in a niche where they are less dependent on functional mitochondria for energy and that mitochondrial activity needs to increase upon differentiation44,45. Interestingly, it was observed that mitochondrial dysfunctions due to Mtu1 deficiency particularly affect the osteogenic differentiation of MSCs. Moreover, RNA-seq analysis revealed that various signaling pathways were dysregulated in MSCs with Mtu1 defects. Among which, the FoxO family of transcription factors were reported to be positive regulator of bone formation and resistance to oxidative stress in osteoblasts39,46,47. Thus, downregulation of a large number of genes in FoxO signaling pathway might be a key regulatory mechanism of Mtul related osteogenesis defects.
In summary, this study demonstrated that Mtu1 deficiency caused inefficient 2-thiouridine modification of U34 of mitochondrial tRNAGln, tRNAGlu, and tRNALys in both primary mouse bone marrow MSCs and MS5 stromal cells, subsequently impairing mitochondrial translation and mitochondrial ATP production, leading to decreased osteogenesis and osteopenia in the mice. These may provide a novel model to study the molecular mechanisms that link mitochondrial dynamics to the osteogenic differentiation regulation.
Horwitz, E. M. et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl Acad. Sci. USA 99, 8932–8937 (2002).
Ichim, T. E. et al. Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy. Reprod. Biomed. Online 16, 898–905 (2008).
Tyndall, A. Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases. Pediatr. Res. 71, 433–438 (2012).
Kharaziha, P. et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur. J. Gastroenterol. Hepatol. 21, 1199–1205 (2009).
Wang, H. et al. Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging. Stem Cells 27, 1548–1558 (2009).
McBride, H. M., Neuspiel, M. & Wasiak, S. Mitochondria: more than just a powerhouse. Curr. Biol. 16, R551–R560 (2006).
Newmeyer, D. D. & Ferguson-Miller, S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112, 481–490 (2003).
Schapira, A. H. Mitochondrial diseases. Lancet 379, 1825–1834 (2012).
Quinn, K. P. et al. Quantitative metabolic imaging using endogenous fluorescence to detect stem cell differentiation. Sci. Rep. 3, 3432 (2013).
Hofmann, A. D. et al. OXPHOS supercomplexes as a hallmark of the mitochondrial phenotype of adipogenic differentiated human MSCs. PLoS ONE 7, e35160 (2012).
Lambertini, E. et al. Osteogenic differentiation of human MSCs: specific occupancy of the mitochondrial DNA by NFATc1 transcription factor. Int. J. Biochem. Cell Biol. 64, 212–219 (2015).
Forni, M. F., Peloggia, J., Trudeau, K., Shirihai, O. & Kowaltowski, A. J. Murine mesenchymal stem cell commitment to differentiation is regulated by mitochondrial dynamics. Stem Cells 34, 743–755 (2016).
Wanet, A. et al. Mitochondrial remodeling in hepatic differentiation and dedifferentiation. Int. J. Biochem. Cell Biol. 54, 174–185 (2014).
Zhang, Y., Marsboom, G., Toth, P. T. & Rehman, J. Mitochondrial respiration regulates adipogenic differentiation of human mesenchymal stem cells. PLoS ONE 8, e77077 (2013).
Li, Q., Gao, Z., Chen, Y. & Guan, M. X. The role of mitochondria in osteogenic, adipogenic and chondrogenic differentiation of mesenchymal stem cells. Protein Cell 8, 439–445 (2017).
Rotig, A. Human diseases with impaired mitochondrial protein synthesis. Biochim. Biophys. Acta 1807, 1198–1205 (2011).
Boczonadi, V. & Horvath, R. Mitochondria: impaired mitochondrial translation in human disease. Int. J. Biochem. Cell Biol. 48, 77–84 (2014).
Wallace, D. C. Mitochondrial diseases in man and mouse. Science 283, 1482–1488 (1999).
Dickinson, M. E. et al. High-throughput discovery of novel developmental phenotypes. Nature 537, 508–514 (2016).
Hance, N., Ekstrand, M. I. & Trifunovic, A. Mitochondrial DNA polymerase gamma is essential for mammalian embryogenesis. Hum. Mol. Genet. 14, 1775–1783 (2005).
Larsson, N. G. et al. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat. Genet. 18, 231–236 (1998).
Park, C. B. et al. MTERF3 is a negative regulator of mammalian mtDNA transcription. Cell 130, 273–285 (2007).
Dogan, S. A. et al. Tissue-specific loss of DARS2 activates stress responses independently of respiratory chain deficiency in the heart. Cell Metab. 19, 458–469 (2014).
Moffat, J. et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124, 1283–1298 (2006).
Chen, Y., Dong, X. J., Zhang, G. R., Shao, J. Z. & Xiang, L. X. In vitro differentiation of mouse bone marrow stromal stem cells into hepatocytes induced by conditioned culture medium of hepatocytes. J. Cell. Biochem. 102, 52–63 (2007).
Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105–1111 (2009).
Torres, A. G., Reina, O., Stephan-Otto Attolini, C. & Ribas de Pouplana, L. Differential expression of human tRNA genes drives the abundance of tRNA-derived fragments. Proc. Natl Acad. Sci. USA 116, 8451–8456 (2019).
Subramanian, A., Kuehn, H., Gould, J., Tamayo, P. & Mesirov, J. P. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 23, 3251–3253 (2007).
Wu, Y. et al. Mtu1-mediated thiouridine formation of mitochondrial tRNAs is required for mitochondrial translation and is involved in reversible infantile liver injury. PLoS Genet. 12, e1006355 (2016).
Morikawa, S. et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J. Exp. Med. 206, 2483–2496 (2009).
Liew, A. et al. Allogeneic mesenchymal stromal cells (MSCs) are of comparable efficacy to syngeneic MSCs for therapeutic revascularization in C57BKSdb/db mice despite the induction of alloantibody. Cell Transplant. 27, 1210–1221 (2018).
Li, X. & Guan, M. X. A human mitochondrial GTP binding protein related to tRNA modification may modulate phenotypic expression of the deafness-associated mitochondrial 12S rRNA mutation. Mol. Cell. Biol. 22, 7701–7711 (2002).
Wang, X., Yan, Q. & Guan, M. X. Mutation in MTO1 involved in tRNA modification impairs mitochondrial RNA metabolism in the yeast Saccharomyces cerevisiae. Mitochondrion 9, 180–185 (2009).
Zhang, Q. et al. Deletion of Mtu1 (Trmu) in zebrafish revealed the essential role of tRNA modification in mitochondrial biogenesis and hearing function. Nucleic Acids Res. 46, 10930–10945 (2018).
Meng, F. et al. Biochemical evidence for a nuclear modifier allele (A10S) in TRMU (Methylaminomethyl-2-thiouridylate-methyltransferase) related to mitochondrial tRNA modification in the phenotypic manifestation of deafness-associated 12S rRNA mutation. J. Biol. Chem. 292, 2881–2892 (2017).
Calvo, S. E., Clauser, K. R. & Mootha, V. K. MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins. Nucleic Acids Res. 44, D1251–D1257 (2016).
Essers, M. A. et al. Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science 308, 1181–1184 (2005).
Almeida, M., Han, L., Martin-Millan, M., O’Brien, C. A. & Manolagas, S. C. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J. Biol. Chem. 282, 27298–27305 (2007).
Atashi, F., Modarressi, A. & Pepper, M. S. The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: a review. Stem Cells Dev. 24, 1150–1163 (2015).
Suzuki, T., Suzuki, T., Wada, T., Saigo, K. & Watanabe, K. Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases. EMBO J. 21, 6581–6589 (2002).
Suzuki, T. & Suzuki, T. A complete landscape of post-transcriptional modifications in mammalian mitochondrial tRNAs. Nucleic Acids Res. 42, 7346–7357 (2014).
Bjork, G. R., Huang, B., Persson, O. P. & Bystrom, A. S. A conserved modified wobble nucleoside (mcm5s2U) in lysyl-tRNA is required for viability in yeast. RNA 13, 1245–1255 (2007).
Kirino, Y., Goto, Y., Campos, Y., Arenas, J. & Suzuki, T. Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease. Proc. Natl Acad. Sci. USA 102, 7127–7132 (2005).
Sanchez-Arago, M., Garcia-Bermudez, J., Martinez-Reyes, I., Santacatterina, F. & Cuezva, J. M. Degradation of IF1 controls energy metabolism during osteogenic differentiation of stem cells. EMBO Rep. 14, 638–644 (2013).
Hsu, Y. C., Wu, Y. T., Yu, T. H. & Wei, Y. H. Mitochondria in mesenchymal stem cell biology and cell therapy: from cellular differentiation to mitochondrial transfer. Semin. Cell Dev. Biol. 52, 119–131 (2016).
Rached, M. T. et al. FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab. 11, 147–160 (2010).
Kops, G. J. et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419, 316–321 (2002).
This work was supported by National Key Research and Development Program of China (2020YFA0113003, 2018YFC1004803), Natural Science Foundation of China (31671305), and the Fundamental Research Funds for the Central Universities. We are grateful to Dr. Min-Xin Guan (Zhejiang University School of Medicine) for technical support and valuable suggestions.
All experiments were performed under the approval of the Animal Ethic Committee of Zhejiang University (Ethical Approval Code: 17264).
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by Y. Wang
About this article
Cite this article
He, Q., Zhao, Q., Li, Q. et al. Mtu1 defects are correlated with reduced osteogenic differentiation. Cell Death Dis 12, 61 (2021). https://doi.org/10.1038/s41419-020-03345-5